Treatment of hyperkalemia

Bibliography

• Floege J, Johnson RJ, Feehally J. Comprehensive clinical nephrology. 4th edition. Saunders/Elsevier, Philadelphia, PA; 2010
   Google Scholar
• Clausen T, Everts ME. Regulation of the Na, K-pump in skeletal muscle. Kidney Int 1989;35:1-13
   PubMed Web of Science ®Google Scholar
• Sandle GI, Gaiger E, Tapster S, et al. Enhanced rectal potassium secretion in chronic renal insufficiency: evidence for large intestinal potassium adaptation in man. Clin Sci (Lond) 1986;71:393-401
   Google Scholar
• Gifford JD, Rutsky EA, Kirk KA, et al. Control of serum potassium during fasting in patients with end-stage renal disease. Kidney Int 1989;35:90-4
   Google Scholar
• Bia MJ, DeFronzo RA. Extrarenal potassium homeostasis. Am J Physiol 1981;240:F257-68
   PubMed Web of Science ®Google Scholar
• DeFronzo RA, Sherwin RS, Dillingham M, et al. Influence of basal insulin and glucagon secretion on potassium and sodium metabolism. Studies with somatostatin in normal dogs and in normal and diabetic human beings. J Clin Invest 1978;61:472-9
   PubMed Web of Science ®Google Scholar
• Dluhy RG, Axelrod L, Williams GH. Serum immunoreactive insulin and growth hormone response to potassium infusion in normal man. J Appl Physiol 1972;33:22-6
   PubMed Web of Science ®Google Scholar
• Rosa RM, Silva P, Young JB, et al. Adrenergic modulation of extrarenal potassium disposal. N Engl J Med 1980;302:431-4
   PubMed Web of Science ®Google Scholar
• Williams ME, Gervino EV, Rosa RM, et al. Catecholamine modulation of rapid potassium shifts during exercise. N Eng J Med 1985;312:823-7
   PubMed Web of Science ®Google Scholar
• Burnell JM, Scribner BH, Uyeno BT, et al. The effect in humans of extracellular pH change on the relationship between serum potassium concentration and intracellular potassium. J Clin Invest 1956;35:935-9
   PubMed Web of Science ®Google Scholar
• Aronson PS, Giebisch G. Effects of pH on potassium: new explanations for old observations. J Am Soc Nephrol 2011;22:1981-9
   PubMed Web of Science ®Google Scholar
• Kaufman JS, Hamburger RJ. Passive potassium transport in the proximal convoluted tubule. Am J Physiol 1985;248:F228-32
   Google Scholar
• Taal MW, Brenner BM, Rector FC. Brenner & Rector's the kidney. 9th edition. Elsevier/Saunders, Philadelphia, PA; 2012
   Google Scholar
• Rieg T, Vallon V, Sausbier M, et al. The role of the BK channel in potassium homeostasis and flow-induced renal potassium excretion. Kidney Int 2007;72:566-73
   PubMed Web of Science ®Google Scholar
• Moranne O, Froissart M, Rossert J, et al. Timing of onset of CKD-related metabolic complications. J Am Soc Nephrol 2009;20:164-71
   PubMed Web of Science ®Google Scholar
• Arlt W, Allolio B. Adrenal insufficiency. Lancet 2003;361:1881-93
   PubMed Web of Science ®Google Scholar
• Speiser PW, White PC. Congenital adrenal hyperplasia. N Engl J Med 2003;349:776-88
   PubMed Web of Science ®Google Scholar
• Lo J, Grinspoon SK. Adrenal function in HIV infection. Curr Opin Endocrinol Diabetes Obes 2010;17:205-9
   Google Scholar
• Oster JR, Singer I, Fishman LM. Heparin-induced aldosterone suppression and hyperkalemia. Am J Med 1995;98:575-86
   PubMed Web of Science ®Google Scholar
• Lush DJ, King JA, Fray JC. Pathophysiology of low renin syndromes: sites of renal renin secretory impairment and prorenin overexpression. Kidney Int 1993;43:983-99
   Web of Science ®Google Scholar
• DuBose TD Jr. Hyperkalemic hyperchloremic metabolic acidosis: pathophysiologic insights. Kidney Int 1997;51:591-602
   Google Scholar
• Geller DS, Zhang J, Zennaro MC, et al. Autosomal dominant pseudohypoaldosteronism type 1: mechanisms, evidence for neonatal lethality, and phenotypic expression in adults. J Am Soc Nephrol 2006;17:1429-36
   Google Scholar
• Mayan H, Vered I, Mouallem M, et al. Pseudohypoaldosteronism type II: marked sensitivity to thiazides, hypercalciuria, normomagnesemia, and low bone mineral density. J Clin Endocrinol Metab 2002;87:3248-54
   PubMed Web of Science ®Google Scholar
• Weir MR, Rolfe M. Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors. Clin J Am Soc Nephrol 2010;5:531-48
   PubMed Web of Science ®Google Scholar
• Conte G, Dal Canton A, Imperatore P, et al. Acute increase in plasma osmolality as a cause of hyperkalemia in patients with renal failure. Kidney Int 1990;38:301-7
   Google Scholar
• Ettinger PO, Regan TJ, Oldewurtel HA. Hyperkalemia, cardiac conduction, and the electrocardiogram: a review. Am Heart J 1974;88:360-71
   PubMed Web of Science ®Google Scholar
• Surawicz B, Chlebus H, Mazzoleni A. Hemodynamic and electrocardiographic effects of hyperpotassemia. Differences in response to slow and rapid increases in concentration of plasma K. Am Heart J 1967;73:647-64
   PubMed Web of Science ®Google Scholar
• Surawicz B. Relationship between electrocardiogram and electrolytes. Am Heart J 1967;73:814-34
   PubMed Web of Science ®Google Scholar
• Evers S, Engelien A, Karsch V, et al. Secondary hyperkalaemic paralysis. J Neurol Neurosurg Psychiatry 1998;64:249-52
   PubMed Web of Science ®Google Scholar
• Parham WA, Mehdirad AA, Biermann KM, et al. Hyperkalemia revisited. Tex Heart Inst J 2006;33:40-7
   PubMed Web of Science ®Google Scholar
• Cote CJ, Drop LJ, Daniels AL, et al. Calcium chloride versus calcium gluconate: comparison of ionization and cardiovascular effects in children and dogs. Anesthesiology 1987;66:465-70
   Google Scholar
• Evans KJ, Greenberg A. Hyperkalemia: a review. J Intensive Care Med 2005;20:272-90
   PubMedGoogle Scholar
• ECC Committee, Subcommittees and Task Forces of the American Heart Association. 2005 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2005;112(24 Suppl):IV1-203
   PubMed Web of Science ®Google Scholar
• Bower JO, Mengle HAK. The additive effects of calcium and digitalis. JAMA 1936;10:1151-3
   Google Scholar
• Blumberg A, Weidmann P, Shaw S, et al. Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure. Am J Med 1988;85:507-12
   PubMed Web of Science ®Google Scholar
• Lens XM, Montoliu J, Cases A, et al. Treatment of hyperkalaemia in renal failure: salbutamol v. insulin. Nephrol Dial Transplant 1989;4:228-32
   PubMedGoogle Scholar
• De Wolf A, Frenette L, Kang Y, et al. Insulin decreases the serum potassium concentration during the anhepatic stage of liver transplantation. Anesthesiology 1993;78:677-82
   Google Scholar
• Kim HJ. Combined effect of bicarbonate and insulin with glucose in acute therapy of hyperkalemia in end-stage renal disease patients. Nephron 1996;72:476-82
   PubMed Web of Science ®Google Scholar
• Evans K, Reddan DN, Szczech LA. Nondialytic management of hyperkalemia and pulmonary edema among end-stage renal disease patients: an evaluation of the evidence. Semin Dial 2004;17:22-9
   Google Scholar
• Emmett M. Non-dialytic treatment of acute hyperkalemia in the dialysis patient. Semin Dial 2000;13:279-80
   Google Scholar
• Allon M, Copkney C. Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients. Kidney Int 1990;38:869-72
   PubMed Web of Science ®Google Scholar
• Ahee P, Crowe AV. The management of hyperkalaemia in the emergency department. J Accid Emerg Med 2000;17:188-91
   PubMedGoogle Scholar
• Mandelberg A, Krupnik Z, Houri S, et al. Salbutamol metered-dose inhaler with spacer for hyperkalemia: how fast? How safe? Chest 1999;115:617-22
   PubMed Web of Science ®Google Scholar
• Allon M, Dunlay R, Copkney C. Nebulized albuterol for acute hyperkalemia in patients on hemodialysis. Ann Intern Med 1989;110:426-9
   PubMedGoogle Scholar
• Liou HH, Chiang SS, Wu SC, et al. Hypokalemic effects of intravenous infusion or nebulization of salbutamol in patients with chronic renal failure: comparative study. Am J Kidney Dis 1994;23:266-71
   Google Scholar
• Montoliu J, Lens XM, Revert L. Potassium-lowering effect of albuterol for hyperkalemia in renal failure. Arch Intern Med 1987;147:713-17
   Google Scholar
• Vitez TS. Treatment of hyperkalemia with epinephrine. Anesthesiology 1986;65:350-1
   Google Scholar
• Allon M. Hyperkalemia in end-stage renal disease: mechanisms and management. J Am Soc Nephrol 1995;6:1134-42
   PubMed Web of Science ®Google Scholar
• Burnell JM, Scribner BH, Uyeno BT, et al. The effect in humans of extracellular pH change on the relationship between serum potassium concentration and intracellular potassium. J Clin Invest 1956;35:935-9
   PubMed Web of Science ®Google Scholar
• Schwarz KC, Cohen BD, Lubash GD, et al. Severe acidosis and hyperpotassemia treated with sodium bicarbonate infusion. Circulation 1959;19:215-20
   Google Scholar
• Allon M, Shanklin N. Effect of bicarbonate administration on plasma potassium in dialysis patients: interactions with insulin and albuterol. Am J Kidney Dis 1996;28:508-14
   Google Scholar
• Gutierrez R, Schlessinger F, Oster JR, et al. Effect of hypertonic versus isotonic sodium bicarbonate on plasma potassium concentration in patients with end-stage renal disease. Miner Electrolyte Metab 1991;17:297-302
   Google Scholar
• Blumberg A, Weidmann P, Ferrari P. Effect of prolonged bicarbonate administration on plasma potassium in terminal renal failure. Kidney Int 1992;41:369-74
   Google Scholar
• Ahmed J, Weisberg LS. Hyperkalemia in dialysis patients. Semin Dial 2001;14:348-56
   PubMed Web of Science ®Google Scholar
• Shankar SS, Brater DC. Loop diuretics: from the Na-K-2Cl transporter to clinical use. Am J Physiol Renal Physiol 2003;284:F11-21
   PubMed Web of Science ®Google Scholar
• Reubi FC, Cottier PT. Effects of reduced glomerular filtration rate on responsiveness to chlorothiazide and mercurial diuretics. Circulation 1961;23:200-10
   PubMed Web of Science ®Google Scholar
• Suki WN. Use of diuretics in chronic renal failure. Kidney Int Suppl 1997;59:S33-5
   Google Scholar
• Ritz E, Fliser D, Nowicki M, et al. Treatment with high doses of loop diuretics in chronic renal failure. Nephrol Dial Transplant 1994;9(Suppl 3):40-3
   Google Scholar
• Scherr L, Ogden DA, Mead AW, et al. Management of hyperkalemia with a cation-exchange resin. N Engl J Med 1961;264:115-19
   PubMed Web of Science ®Google Scholar
• Weiner ID, Wingo CS. Hyperkalemia: a potential silent killer. J Am Soc Nephrol 1998;9:1535-43
   PubMed Web of Science ®Google Scholar
• Paice B, Gray JM, McBride D, et al. Hyperkalaemia in patients in hospital. Br Med J 1983;286:1189-92
   PubMedGoogle Scholar
• Watson M, Abbott KC, Yuan CM. Damned if you do, damned if you don't: potassium binding resins in hyperkalemia. Clin J Am Soc Nephrol 2010;5:1723-6
   PubMed Web of Science ®Google Scholar
• Flinn RB, Merrill JP, Welzant WR. Treatment of the oliguric patient with a new sodium-exchange resin and sorbitol; a preliminary report. N Engl J Med 1961;264:111-15
   PubMed Web of Science ®Google Scholar
• Lillemoe KD, Romolo JL, Hamilton SR, et al. Intestinal necrosis due to sodium polystyrene (Kayexalate) in sorbitol enemas: clinical and experimental support for the hypothesis. Surgery 1987;101:267-72
   PubMed Web of Science ®Google Scholar
• Gerstman BB, Kirkman R, Platt R. Intestinal necrosis associated with postoperative orally administered sodium polystyrene sulfonate in sorbitol. Am J Kidney Dis 1992;20:159-61
   PubMed Web of Science ®Google Scholar
• Gruy-Kapral C, Emmett M, Santa Ana CA, et al. Effect of single dose resin-cathartic therapy on serum potassium concentration in patients with end-stage renal disease. J Am Soc Nephrol 1998;9:1924-30
   PubMed Web of Science ®Google Scholar
• Sterns RH, Rojas M, Bernstein P, et al. Ion-exchange resins for the treatment of hyperkalemia: are they safe and effective? J Am Soc Nephrol 2010;21:733-5
   PubMed Web of Science ®Google Scholar
• Kessler C, Ng J, Valdez K, et al. The use of sodium polystyrene sulfonate in the inpatient management of hyperkalemia. J Hosp Med 2011;6:136-40
   PubMed Web of Science ®Google Scholar
• Fordjour KN, Walton T, Doran JJ. Management of Hyperkalemia in Hospitalized Patients. Am J Med Sci 2012; Epub ahead of print
   Google Scholar
• Watson MA, Baker TP, Nguyen A, et al. Association of prescription of oral sodium polystyrene sulfonate with sorbitol in an inpatient setting with colonic necrosis: a retrospective cohort study. Am J Kidney Dis 2012;60:409-16
   PubMed Web of Science ®Google Scholar
• Harel Z, Harel S, Shah PS, et al. Gastrointestinal adverse events with sodium polystyrene sulfonate (kayexalate) use: a systematic review. Am J Med 2013;126:264 e9-64 e24
   Web of Science ®Google Scholar
• Pitt B, Anker SD, Bushinsky DA, et al. Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial. Eur Heart J 2011;32:820-8
   PubMed Web of Science ®Google Scholar
• Buysse JM, Huang IZ, Pitt B. PEARL-HF: prevention of hyperkalemia in patients with heart failure using a novel polymeric potassium binder, RLY5016. Future Cardiol 2012;81:17-28
   Google Scholar
• Blumberg A, Roser HW, Zehnder C, et al. Plasma potassium in patients with terminal renal failure during and after haemodialysis; relationship with dialytic potassium removal and total body potassium. Nephrol Dial Transplant 1997;12:1629-34
   PubMed Web of Science ®Google Scholar
• Hou S, McElroy PA, Nootens J, et al. Safety and efficacy of low-potassium dialysate. Am J Kidney Dis 1989;13:137-43
   PubMed Web of Science ®Google Scholar
• Zehnder C, Gutzwiller JP, Huber A, et al. Low-potassium and glucose-free dialysis maintains urea but enhances potassium removal. Nephrol Dial Transplant 2001;16:78-84
   Web of Science ®Google Scholar
• Gutzwiller JP, Schneditz D, Huber AR, et al. Increasing blood flow increases kt/V(urea) and potassium removal but fails to improve phosphate removal. Clin Nephrol 2003;59:130-6
   PubMedGoogle Scholar
• Heguilén RM, Sciurano C, Bellusci AD, et al. The faster potassium-lowering effect of high dialysate bicarbonate concentrations in chronic haemodialysis patients. Nephrol Dial Transplant 2005;20:591-7
   PubMedGoogle Scholar
• Ward RA, Wathen RL, Williams TE, et al. Hemodialysate composition and intradialytic metabolic, acid-base and potassium changes. Kidney Int 1987;32:129-35
   Google Scholar
• Sherman RA, Hwang ER, Bernholc AS, et al. Variability in potassium removal by hemodialysis. Am J Nephrol 1986;6:284-8
   Google Scholar
• Acker CG, Johnson JP, Palevsky PM, et al. Hyperkalemia in hospitalized patients: causes, adequacy of treatment, and results of an attempt to improve physician compliance with published therapy guidelines. Arch Intern Med 1998;158:917-24
   PubMed Web of Science ®Google Scholar
• Szerlip HM, Weiss J, Singer I. Profound hyperkalemia without electrocardiographic manifestations. Am J Kidney Dis 1986;7:461-5
   Web of Science ®Google Scholar
• Einhorn LM, Zhan M, Hsu VD, et al. The frequency of hyperkalemia and its significance in chronic kidney disease. Arch Intern Med 2009;169:1156-62
   PubMed Web of Science ®Google Scholar
• Frohnert PP, Giuliani ER, Friedberg M, et al. Statistical investigation of correlations between serum potassium levels and electrocardiographic findings in patients on intermittent hemodialysis therapy. Circulation 1970;41:667-76
   Google Scholar
• Surawicz B, Chlebus H, Mazzoleni A. Hemodynamic and electrocardiographic effects of hyperpotassemia. Differences in response to slow and rapid increases in concentration of plasma K. Am Heart J 1967;73:647-64
   PubMed Web of Science ®Google Scholar
• Kelly RA, Smith TW. Recognition and management of digitalis toxicity. Am J Cardiol 1992;69:108G-18G. disc 18G-19G
   PubMed Web of Science ®Google Scholar
• Shrager MW. Digitalis intoxication; a review and report of forty cases, with emphasis on etiology. AMA Arch Intern Med 1957;100:881-93
   Google Scholar
• Gold H, Edwards D. The effects of ouabain on the heart in the presence of hypercalcemia. Am Heart J. 1927;3:45-50
   Google Scholar
• Smith P, Winkler A, Hoff H. Calcium and digitalis synergism: the toxicity of calcium salts injected intravenously into digitized animals. Arch Intern Med 1939;63:322-9
   Google Scholar
• Nola GT, Pope S, Harrison DC. Assessment of the synergistic relationship between serum calcium and digitalis. Am Heart J 1970;79:499-507
   PubMed Web of Science ®Google Scholar
• Hack JB, Woody JH, Lewis DE, et al. The effect of calcium chloride in treating hyperkalemia due to acute digoxin toxicity in a porcine model. J Toxicol Clin Toxicol 2004;42:337-42
   PubMed Web of Science ®Google Scholar
• Levine M, Nikkanen H, Pallin DJ. The effects of intravenous calcium in patients with digoxin toxicity. J Emerg Med 2011;40:41-6
   PubMed Web of Science ®Google Scholar
• Spiegel A, Marchlinski FE. Time course for reversal of digoxin toxicity with digoxin-specific antibody fragments. Am Heart J 1985;109:1397-9
   PubMed Web of Science ®Google Scholar
• Weisberg LS, Rachoin JS. The safety of low-potassium dialysis. Semin Dial 2010;23:556-60
   PubMed Web of Science ®Google Scholar
• Ritz E, Wanner C. The challenge of sudden death in dialysis patients. Clin J Am Soc Nephrol 2008;3:920-9
   PubMedGoogle Scholar
• Morrison G, Michelson EL, Brown S, et al. Mechanism and prevention of cardiac arrhythmias in chronic hemodialysis patients. Kidney Int 1980;17:811-19
   PubMed Web of Science ®Google Scholar
• Saragoca MA, Canziani ME, Cassiolato JL, et al. Left ventricular hypertrophy as a risk factor for arrhythmias in hemodialysis patients. J Cardiovasc Pharmacol 1991;17(Suppl 2):S136-8
   PubMedGoogle Scholar
• Buemi M, Aloisi E, Coppolino G, et al. The effect of two different protocols of potassium haemodiafiltration on QT dispersion. Nephrol Dial Transplant 2005;20:1148-54
   PubMed Web of Science ®Google Scholar
• Karnik JA, Young BS, Lew NL, et al. Cardiac arrest and sudden death in dialysis units. Kidney Int 2001;60:350-7
   PubMed Web of Science ®Google Scholar